1. Home
  2. FSFG vs FENC Comparison

FSFG vs FENC Comparison

Compare FSFG & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSFG
  • FENC
  • Stock Information
  • Founded
  • FSFG 2008
  • FENC 1996
  • Country
  • FSFG United States
  • FENC United States
  • Employees
  • FSFG N/A
  • FENC N/A
  • Industry
  • FSFG Savings Institutions
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FSFG Finance
  • FENC Health Care
  • Exchange
  • FSFG Nasdaq
  • FENC Nasdaq
  • Market Cap
  • FSFG N/A
  • FENC 156.9M
  • IPO Year
  • FSFG 2008
  • FENC 2001
  • Fundamental
  • Price
  • FSFG $25.06
  • FENC $6.06
  • Analyst Decision
  • FSFG Buy
  • FENC Strong Buy
  • Analyst Count
  • FSFG 1
  • FENC 2
  • Target Price
  • FSFG $31.00
  • FENC $14.00
  • AVG Volume (30 Days)
  • FSFG 12.4K
  • FENC 69.5K
  • Earning Date
  • FSFG 01-28-2025
  • FENC 03-20-2025
  • Dividend Yield
  • FSFG 2.34%
  • FENC N/A
  • EPS Growth
  • FSFG 66.39
  • FENC N/A
  • EPS
  • FSFG 1.98
  • FENC N/A
  • Revenue
  • FSFG $68,091,000.00
  • FENC $49,348,000.00
  • Revenue This Year
  • FSFG N/A
  • FENC $170.43
  • Revenue Next Year
  • FSFG $2.77
  • FENC $6.70
  • P/E Ratio
  • FSFG $12.86
  • FENC N/A
  • Revenue Growth
  • FSFG N/A
  • FENC 278.09
  • 52 Week Low
  • FSFG $14.55
  • FENC $3.96
  • 52 Week High
  • FSFG $30.94
  • FENC $11.49
  • Technical
  • Relative Strength Index (RSI)
  • FSFG 45.58
  • FENC 56.21
  • Support Level
  • FSFG $24.24
  • FENC $5.45
  • Resistance Level
  • FSFG $26.12
  • FENC $6.19
  • Average True Range (ATR)
  • FSFG 0.81
  • FENC 0.27
  • MACD
  • FSFG 0.11
  • FENC -0.02
  • Stochastic Oscillator
  • FSFG 48.48
  • FENC 68.13

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: